Silo Pharma Approved Extension Of Previously Announced Stock Repurchase Program Authorizing Purchase Of Up To $1M Common Stock Until April 30
Silo Pharma Approved Extension Of Previously Announced Stock Repurchase Program Authorizing Purchase Of Up To $1M Common Stock Until April 30
Silo Pharma批准將先前宣佈的股票回購計劃延長至4月30日，該計劃授權購買高達100萬美元的普通股
Silo Pharma Approved Extension Of Previously Announced Stock Repurchase Program Authorizing Purchase Of Up To $1M Common Stock Until April 30
Silo Pharma批准將先前宣佈的股票回購計劃延長至4月30日，該計劃授權購買高達100萬美元的普通股
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。